Перейти к содержанию

Supernus, Inc. (SUPN) stock: revenue, earnings & dividend

Supernus, Inc. (SUPN, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener SUPN · Nasdaq Pharma & Biotech US-VA

Key figures

Fiscal year
2025
Revenue
1.24 bn $
Revenue growth
4.3 %
Revenue growth 5y (p.a.)
–
Net income
210 m $
Net margin
17 %
Operating margin
21.2 %
Earnings per share (diluted)
1.64 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
1.2 bn $
Equity
-98 m $
Equity ratio
-8.2 %
Return on equity
–
Cash
195 m $
Operating cash flow
-27 m $
Free cash flow
-93 m $
Shares outstanding
118,035,272

History

Revenue by fiscal year

2022 901 m $
2023 1.09 bn $
2024 1.19 bn $
2025 1.24 bn $

Net income by fiscal year

2022 -42 m $
2023 -126 m $
2024 7 m $
2025 210 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.24 bn $210 m $1.64 $–-27 m $
20241.19 bn $7 m $0.05 $–36 m $
20231.09 bn $-126 m $-0.92 $–-300 m $
2022901 m $-42 m $-0.30 $–-4 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)